Annual report pursuant to Section 13 and 15(d)

Consolidating Condensed Financial Information of Guarantor Subsidiaries - Consolidating Condensed Statement of Cash Flows (Detail)

v3.10.0.1
Consolidating Condensed Financial Information of Guarantor Subsidiaries - Consolidating Condensed Statement of Cash Flows (Detail) - USD ($)
$ in Thousands
12 Months Ended
Sep. 29, 2018
Sep. 30, 2017
Sep. 24, 2016
Condensed Financial Statements, Captions [Line Items]      
Net cash provided (used) by operating activities $ 114,112 $ 114,309 $ 151,426
Additions to property, plant and equipment (37,845) (44,659) (27,622)
Businesses acquired, net of cash acquired, and investments in joint ventures (91,244) (103,880) (69,001)
Proceeds from asset sales 0 8,547 3,911
Escrow deposit for acquisition-related contingent consideration 0 (6,000) 0
Change in restricted cash and cash equivalents. 1,746 (1,735) 2,247
Payments for investments (9,048) (12,495) 0
Other investing activities (2,745) (4,355) (730)
Intercompany investing activities 0 0 0
Net cash used in investing activities (139,136) (164,577) (91,195)
Repayments on revolving line of credit (23,000) (552,000) (419,000)
Borrowings on revolving line of credit 23,000 552,000 419,000
Repayments of long-term debt (431) (463) (400,307)
Issuance of long-term debt 300,000 0 400,000
Proceeds from issuance of common stock, net of offering costs 195,631 0 324
Excess tax benefits from stock-based awards 0 19,946 6,869
Repurchase of common stock (13,797) (27,556) (10,873)
Payments of contingent consideration (253) (1,300) (2,026)
Payment of deferred financing costs (4,770) 0 (7,560)
Distribution to parent 0 0 0
Distribution to noncontrolling interest (1,597) (1,019) (592)
Intercompany financing activities 0 0 0
Net cash provided (used) by financing activities 474,783 (10,392) (14,165)
Effect of exchange rates on cash (50) 75 (668)
Net increase (decrease) in cash and cash equivalents 449,709 (60,585) 45,398
Cash and cash equivalents at beginning of year 32,397 92,982 47,584
Cash and cash equivalents at end of year 482,106 32,397 92,982
Eliminations      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided (used) by operating activities (6,387) (4,076) (4,883)
Additions to property, plant and equipment 0 0 0
Businesses acquired, net of cash acquired, and investments in joint ventures 0 0 0
Proceeds from asset sales   0
Escrow deposit for acquisition-related contingent consideration   0  
Change in restricted cash and cash equivalents. 0 0 0
Payments for investments   0  
Other investing activities 0 0 0
Intercompany investing activities 111,509 98,591 129,791
Net cash used in investing activities 111,509 98,591 129,791
Repayments on revolving line of credit 0 0 0
Borrowings on revolving line of credit 0 0 0
Repayments of long-term debt 0 0 0
Issuance of long-term debt 0  
Proceeds from issuance of common stock, net of offering costs 0   0
Excess tax benefits from stock-based awards   0 0
Repurchase of common stock 0 0 0
Payments of contingent consideration 0
Payment of deferred financing costs 0   0
Distribution to parent 6,387 4,076 4,883
Distribution to noncontrolling interest 0 0 0
Intercompany financing activities (111,509) (98,591) (129,791)
Net cash provided (used) by financing activities (105,122) (94,515) (124,908)
Effect of exchange rates on cash 0 0 0
Net increase (decrease) in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of year 0 0 0
Cash and cash equivalents at end of year 0 0 0
Parent | Reportable Legal Entities      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided (used) by operating activities (16,676) (7,418) 3,906
Additions to property, plant and equipment (6,633) (9,419) (4,513)
Businesses acquired, net of cash acquired, and investments in joint ventures (91,244) (103,880) (69,001)
Proceeds from asset sales   229 0
Escrow deposit for acquisition-related contingent consideration   (6,000)  
Change in restricted cash and cash equivalents. 1,746 (1,735) 2,247
Payments for investments (9,048) (12,495)  
Other investing activities (2,745) (4,355) (730)
Intercompany investing activities (3,760) (3,828) (83)
Net cash used in investing activities (111,684) (141,483) (72,080)
Repayments on revolving line of credit (23,000) (552,000) (419,000)
Borrowings on revolving line of credit 23,000 552,000 419,000
Repayments of long-term debt (56) (89) (400,286)
Issuance of long-term debt 300,000   400,000
Proceeds from issuance of common stock, net of offering costs 195,631   324
Excess tax benefits from stock-based awards   19,946 6,869
Repurchase of common stock (13,797) (27,556) (10,873)
Payments of contingent consideration 0 0 0
Payment of deferred financing costs (4,770)   (7,560)
Distribution to parent 0 0 0
Distribution to noncontrolling interest 0 0 0
Intercompany financing activities 106,525 93,445 127,044
Net cash provided (used) by financing activities 583,533 85,746 115,518
Effect of exchange rates on cash (201) 235 (1,466)
Net increase (decrease) in cash and cash equivalents 454,972 (62,920) 45,878
Cash and cash equivalents at beginning of year 19,238 82,158 36,280
Cash and cash equivalents at end of year 474,210 19,238 82,158
Non-Guarantor Subsidiaries | Reportable Legal Entities      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided (used) by operating activities (1,288) 2,846 2,654
Additions to property, plant and equipment (1,495) (805) (717)
Businesses acquired, net of cash acquired, and investments in joint ventures 0 0 0
Proceeds from asset sales   0
Escrow deposit for acquisition-related contingent consideration   0  
Change in restricted cash and cash equivalents. 0 0 0
Payments for investments   0  
Other investing activities 0 0 0
Intercompany investing activities 0 0 0
Net cash used in investing activities (1,495) (805) (717)
Repayments on revolving line of credit 0 0 0
Borrowings on revolving line of credit 0 0 0
Repayments of long-term debt 0 0 0
Issuance of long-term debt 0  
Proceeds from issuance of common stock, net of offering costs 0   0
Excess tax benefits from stock-based awards   0 0
Repurchase of common stock 0 0 0
Payments of contingent consideration 0
Payment of deferred financing costs 0   0
Distribution to parent (6,387) (4,076) (4,883)
Distribution to noncontrolling interest (1,597) (1,019) (592)
Intercompany financing activities 4,984 5,146 2,747
Net cash provided (used) by financing activities (3,000) 51 (2,728)
Effect of exchange rates on cash 95 (94) 464
Net increase (decrease) in cash and cash equivalents (5,688) 1,998 (327)
Cash and cash equivalents at beginning of year 11,693 9,695 10,022
Cash and cash equivalents at end of year 6,005 11,693 9,695
Guarantor Subsidiaries | Reportable Legal Entities      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided (used) by operating activities 138,463 122,957 149,749
Additions to property, plant and equipment (29,717) (34,435) (22,392)
Businesses acquired, net of cash acquired, and investments in joint ventures 0 0 0
Proceeds from asset sales   8,318 3,911
Escrow deposit for acquisition-related contingent consideration   0  
Change in restricted cash and cash equivalents. 0 0 0
Payments for investments   0  
Other investing activities 0 0 0
Intercompany investing activities (107,749) (94,763) (129,708)
Net cash used in investing activities (137,466) (120,880) (148,189)
Repayments on revolving line of credit 0 0 0
Borrowings on revolving line of credit 0 0 0
Repayments of long-term debt (375) (374) (21)
Issuance of long-term debt 0  
Proceeds from issuance of common stock, net of offering costs 0   0
Excess tax benefits from stock-based awards   0 0
Repurchase of common stock 0 0 0
Payments of contingent consideration (253) (1,300) (2,026)
Payment of deferred financing costs 0   0
Distribution to parent 0 0 0
Distribution to noncontrolling interest 0 0 0
Intercompany financing activities 0 0 0
Net cash provided (used) by financing activities (628) (1,674) (2,047)
Effect of exchange rates on cash 56 (66) 334
Net increase (decrease) in cash and cash equivalents 425 337 (153)
Cash and cash equivalents at beginning of year 1,466 1,129 1,282
Cash and cash equivalents at end of year $ 1,891 $ 1,466 $ 1,129